Abstract: The present utility model relates to a fuse, a vehicle circuit for an electric vehicle, and an electric vehicle. The fuse has a longitudinal direction and a transverse direction, and includes: a bushing, having a through-hole cavity extending in the longitudinal direction and for accommodating quartz sand; a fuse body, accommodated in the through-hole cavity and having a plurality of openings spaced apart from each other in the transverse direction; and two contact blades, positioned at two ends of the through-hole cavity and each soldered to the fuse body by a conductive plate. An arc extinguishing medium layer is provided on the fuse body. A side edge of the arc extinguishing medium layer contacts edges of any two adjacent openings of the plurality of openings so as to cause the arc extinguishing medium layer to be close to a minimum transverse spacing between the two opening edges.

Abstract: Embodiments of the present application relate to a method for scheduling virtual disk input and output (I/O) ports, a device for scheduling virtual disk I/O ports, and a computer program product for scheduling virtual disk I/O ports. A method for scheduling virtual disk I/O ports is provided. The method includes assigning a set of service quality ratings to a corresponding set of virtual disk I/O ports based on a set of reading-writing bandwidth quotas associated with the corresponding set of virtual disk I/O ports in a physical machine, determining a total forecast value of a data bandwidth to be used by reading-writing requests and determining virtual disk I/O ports, allocating reading-writing bandwidth limits to the virtual disk I/O ports, and scheduling virtual disk I/O ports on the physical machine.

Abstract: A secondary high energy density lithium ion cell includes a cathode comprising a high voltage cathode active material, a lithium metal anode, and a non-aqueous electrolyte, wherein the non-aqueous electrolyte comprises an imide salt with a fluorosulfonyl group and a perchlorate salt, wherein the electrolyte is electrochemically stable at operating voltages greater than 4.2V.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: The invention provides a device for full-automatic, ultra-low pressure, fractionation-free and non-destructive extraction of water, including a control box, an extraction part, an ultra-low temperature cold trap and a transmission device, wherein the control box and the extraction part are located at the top of a cabinet, the ultra-low temperature cold trap is located inside the cabinet, a touch screen is arranged on the control box, a temperature control meter is arranged on a side face of the control box, the extraction part includes an upper layer plate, a middle layer plate, a bottom plate and a test tube, the bottom plate is fixedly installed on the cabinet, the test tube is accommodated in the ultra-low temperature cold trap, and the transmission device is fixedly installed on the bottom plate.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: Embodiments of the present application relate to a method for scheduling virtual disk input and output (I/O) ports, a device for scheduling virtual disk I/O ports, and a computer program product for scheduling virtual disk I/O ports. A method for scheduling virtual disk I/O ports is provided. The method includes assigning a set of service quality ratings to a corresponding set of virtual disk I/O ports based on a set of reading-writing bandwidth quotas associated with the corresponding set of virtual disk I/O ports in a physical machine, determining a total forecast value of a data bandwidth to be used by reading-writing requests and determining virtual disk I/O ports, allocating reading-writing bandwidth limits to the virtual disk I/O ports, and scheduling virtual disk I/O ports on the physical machine.

Abstract: The application describes small molecules capable of modulating activity of beta2 family of integrins, such as integrin CD11b/CD18 (also known as Mac-1, CR3 and ?M?2). Such compounds may be used in certain embodiments for treating a disease or condition, such as inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, wound-healing, organ transplantation and cardiovascular disease, among others.

Abstract: Embodiments of the present application relate to a method for scheduling virtual disk input and output (I/O) ports, a device for scheduling virtual disk I/O ports, and a computer program product for scheduling virtual disk I/O ports. A method for scheduling virtual disk I/O ports is provided. The method includes assigning a set of service quality ratings to a corresponding set of virtual disk I/O ports based on a set of reading-writing bandwidth quotas associated with the corresponding set of virtual disk I/O ports in a physical machine, determining a total forecast value of a data bandwidth to be used by reading-writing requests and determining virtual disk I/O ports, allocating reading-writing bandwidth limits to the virtual disk I/O ports, and scheduling virtual disk I/O ports on the physical machine.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: The invention provides a device for full-automatic, ultra-low pressure, fractionation-free and non-destructive extraction of water, including a control box, an extraction part, an ultra-low temperature cold trap and a transmission device, wherein the control box and the extraction part are located at the top of a cabinet, the ultra-low temperature cold trap is located inside the cabinet, a touch screen is arranged on the control box, a temperature control meter is arranged on a side face of the control box, the extraction part includes an upper layer plate, a middle layer plate, a bottom plate and a test tube, the bottom plate is fixedly installed on the cabinet, the test tube is accommodated in the ultra-low temperature cold trap, and the transmission device is fixedly installed on the bottom plate.

Abstract: A mixer connection mechanism convenient to be mounted on a countertop is provided, which may be provided to be mounted to a countertop of a sink having a mounting hole. The mixer connection mechanism includes a base seat, a locking device, a screw rod assembly, and a position-limiting blocking lever. The screw rod assembly and position-limiting blocking lever are arranged between the base seat and the locking device. When mounted, the screw rod assembly is screwed up by an operation above the countertop of the sink to allow the screw rod assembly to be rotated, whereby rotation of the locking device is limited by the position-limiting blocking lever. Further, the locking device moves towards the countertop of the sink and abuts against a lower surface of the countertop of the sink. Meanwhile, an abutting end at the bottom of the surrounding wall abuts against the countertop of the sink.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: A mixer connection mechanism convenient to be mounted on a countertop is provided, which may be provided to be mounted to a countertop of a sink having a mounting hole. The mixer connection mechanism includes a base seat, a locking device, a screw rod assembly, and a position-limiting blocking lever. The screw rod assembly and position-limiting blocking lever are arranged between the base seat and the locking device. When mounted, the screw rod assembly is screwed up by an operation above the countertop of the sink to allow the screw rod assembly to be rotated, whereby rotation of the locking device is limited by the position-limiting blocking lever. Further, the locking device moves towards the countertop of the sink and abuts against a lower surface of the countertop of the sink. Meanwhile, an abutting end at the bottom of the surrounding wall abuts against the countertop of the sink.

Abstract: A secondary high energy density lithium ion cell includes a cathode comprising a high voltage cathode active material, a lithium metal anode, and a non-aqueous electrolyte, wherein the non-aqueous electrolyte comprises an imide salt with a fluorosulfonyl group and a perchlorate salt, wherein the electrolyte is electrochemically stable at operating voltages greater than 4.2V.

Abstract: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Abstract: A rechargeable lithium battery is an electrochemical energy storage device that includes a cathode, an anode, and a liquid electrolyte as active components. The present disclosure relates to new rechargeable batteries that include a liquid electrolyte with high salt concentration that enables efficient deposition/dissolution of lithium metal on anode, during charge/discharge cycles. The battery can attain high energy density and improved cycle life.